Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02150889 · ClinicalTrials.gov registry record · NA

Training Effects on Fuel Metabolism

A NA study of Overweight and Obesity and Healthy Subjects, sponsored by University of Minnesota.

Active
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT02150889: Active NA study of Overweight and Obesity and Healthy Subjects, sponsored by University of Minnesota.

NCT02150889 is a NA study of Overweight and Obesity and Healthy Subjects that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 64 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02150889, a NA study of Overweight and Obesity and Healthy Subjects, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

The investigators are interested in how skeletal muscle processes fat and how this may affect insulin resistance. This is an important question since insulin resistance predates and predicts type 2 diabetes. The investigators are especially interested in learning about the effects of weight and training on insulin resistance. The investigators will study people before and after supervised aerobic or yoga training to identify differences in resting fat and sugar metabolism which may lead to differences in insulin resistance. The investigators will test these differences using stable isotopes, and the use of these stable isotopes is experimental. Overweight/Obese Group: Eight visits will be required at the University of Minnesota Clinical Research Unit. Four visits will be done before training (screen and 3 pre-training visits), 1 visit during the training, and 3 post-training visits will be done. In between, the training will take about 16 weeks and will be a supervised treadmill program. Lean/Trained Group: Four visits will be required at the University of Minnesota Clinical Research Unit (screen and 3 study visits).

Primary Outcome

Will use HOMA-IR and hyperinsulinemia-euglycemic clamp

Interventions

  • BEHAVIORAL Running Program
  • BEHAVIORAL Yoga Program

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2014-07-01
Est. Completion 2026-12-31
Phase NA
University of Minnesota

966 total trials

What the registry record for NCT02150889 still lists

NCT02150889 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (72% lower).

The record links to 3 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Running Program is the first listed.

NCT02150889 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02150889 about?

NCT02150889 is a clinical study titled "Training Effects on Fuel Metabolism". The investigators are interested in how skeletal muscle processes fat and how this may affect insulin resistance. This is an important question since insulin resistance predates and predicts type 2 diabetes. The investigators are especially interested in learning about the effects of weight and trai...

What is the current status of trial NCT02150889?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2014-07-01. Estimated completion is 2026-12-31.

What conditions does trial NCT02150889 study?

This clinical trial studies the following conditions: Overweight and Obesity, Healthy Subjects, Lean Trained Subjects.

What interventions are being tested in trial NCT02150889?

The interventions under investigation include: Running Program (BEHAVIORAL), Yoga Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02150889?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02150889 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02150889's enrollment target sits among peer trials

64 77th of 115 higher than 38 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01853631 · 64 participants · Phase 1

    Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

  • NCT03739502 · 64 participants · Phase 2

    A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

  • NCT03739814 · 64 participants · Phase 2

    Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • NCT03866408 · 64 participants · Early Phase 1

    Insulin Regulation of Lipolysis and Lipolysis Proteins

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02150889, the US trial registry maintained by the National Library of Medicine. NCT02150889 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.